be_ixf;ym_202405 d_02; ct_50

Latest Insights on GM

Gene Editing Will Make Spoiled Food a Thing of the Past
by Ian Dyer July 10, 2018 Technology, Trending
Of course, performing gene editing on humans and animals is understandably controversial. But with plants, we’ve already seen enormous benefits.
Amazon’s PillPack Deal Could Revolutionize Pharma – Invest Now This news sent many pharmacy-related stocks significantly lower. It’s a bloodbath that is déjà vu to me, because I’ve seen it before.
This Controversial Sector Will Spawn the Next Starbucks Some investors will find this sector distasteful thanks to its decades of stigma. For those investors with a more objective view, there will be huge gains.
Excellent Investing Opportunity Invest in This Hated Stock Now While It’s Incredibly Cheap If you're investing for the long haul, this hated stock is an excellent opportunity now, and one that should be in every long-term investor’s portfolio.
Do You Hold the Bias That Caused the 2008 Crisis?
by Jessica Cohn June 23, 2018 Economy
Today, I want to continue with my expose on investor biases and give you one big reason you’re getting in your own way when you make your trades.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

Share This